14,108 Shares in NanoString Technologies, Inc. (NASDAQ:NSTG) Bought by Ergoteles LLC

Ergoteles LLC purchased a new position in NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 14,108 shares of the biotechnology company’s stock, valued at approximately $180,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Invesco Ltd. increased its stake in shares of NanoString Technologies by 2.7% in the first quarter. Invesco Ltd. now owns 1,655,562 shares of the biotechnology company’s stock worth $57,531,000 after buying an additional 44,127 shares during the last quarter. Polar Capital Holdings Plc increased its stake in shares of NanoString Technologies by 36.7% in the first quarter. Polar Capital Holdings Plc now owns 1,617,733 shares of the biotechnology company’s stock worth $56,216,000 after buying an additional 434,081 shares during the last quarter. State Street Corp increased its stake in shares of NanoString Technologies by 4.5% in the first quarter. State Street Corp now owns 926,443 shares of the biotechnology company’s stock worth $32,194,000 after buying an additional 40,245 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of NanoString Technologies by 71.5% in the second quarter. Goldman Sachs Group Inc. now owns 802,763 shares of the biotechnology company’s stock worth $10,195,000 after buying an additional 334,794 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in shares of NanoString Technologies by 137.8% in the third quarter. Assenagon Asset Management S.A. now owns 737,505 shares of the biotechnology company’s stock worth $9,418,000 after buying an additional 427,401 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Canaccord Genuity Group decreased their price objective on shares of NanoString Technologies from $30.00 to $14.00 in a report on Thursday, November 10th. Cowen decreased their price objective on shares of NanoString Technologies from $31.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, November 8th. Cowen decreased their price objective on shares of NanoString Technologies from $31.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, November 8th. UBS Group assumed coverage on shares of NanoString Technologies in a report on Thursday, February 2nd. They issued a “buy” rating and a $15.00 price objective for the company. Finally, Morgan Stanley decreased their price objective on shares of NanoString Technologies from $17.00 to $16.00 and set an “equal weight” rating for the company in a report on Thursday, March 2nd. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, NanoString Technologies presently has an average rating of “Moderate Buy” and an average target price of $20.57.

Insider Activity

In other news, CEO R Bradley Gray purchased 62,500 shares of NanoString Technologies stock in a transaction dated Monday, December 12th. The stock was bought at an average price of $7.35 per share, with a total value of $459,375.00. Following the completion of the acquisition, the chief executive officer now owns 264,837 shares in the company, valued at approximately $1,946,551.95. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO K Thomas Bailey acquired 29,161 shares of NanoString Technologies stock in a transaction that occurred on Tuesday, December 13th. The stock was acquired at an average price of $8.05 per share, with a total value of $234,746.05. Following the completion of the acquisition, the chief financial officer now directly owns 48,533 shares of the company’s stock, valued at approximately $390,690.65. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO R Bradley Gray acquired 62,500 shares of NanoString Technologies stock in a transaction that occurred on Monday, December 12th. The stock was bought at an average cost of $7.35 per share, with a total value of $459,375.00. Following the acquisition, the chief executive officer now directly owns 264,837 shares of the company’s stock, valued at $1,946,551.95. The disclosure for this purchase can be found here. Corporate insiders own 2.50% of the company’s stock.

NanoString Technologies Stock Performance

Shares of NSTG opened at $9.74 on Wednesday. NanoString Technologies, Inc. has a 1 year low of $4.37 and a 1 year high of $37.06. The company has a market cap of $455.74 million, a price-to-earnings ratio of -2.82 and a beta of 1.59. The company has a debt-to-equity ratio of 4.95, a quick ratio of 4.14 and a current ratio of 4.87. The firm has a fifty day moving average of $10.14 and a 200-day moving average of $10.28.

NanoString Technologies Profile

(Get Rating)

NanoString Technologies, Inc engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular.